Presenters will discuss potential Medicare Part D program changes as it relates to pharmaceutical manufacturer and pharmacy rebates.
They will also review the impacts these changes could have on various stakeholders, and what Part D plan sponsors should be aware of.
- Julia Friedman, Milliman, Inc.
- Dan Hoffman, Optum
- Katherine Margaret Holcomb, Milliman Inc.
- Brandy Nicole Millen, Milliman Inc.
- Troy Wieck, CVSHealth
Continue by clicking on the following link: